Terms: = Breast cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA
977 results:
1. Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer.
Montaseri H; Abrahamse H
Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):270-277. PubMed ID: 38696132
[TBL] [Abstract] [Full Text] [Related]
2. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
3. Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy.
Munderere R; Gulfam M; Ali I; Kim SH; Vu TT; Park SH; Lim KT
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611843
[TBL] [Abstract] [Full Text] [Related]
4. Application of fluorocarbon nanoparticles of
Zhi L; Cheng C; Jing L; Zhi-Ping P; Lu Y; Yan T; Zhi-Gang W; Guo-Bing Y
J Nanobiotechnology; 2024 Mar; 22(1):107. PubMed ID: 38475902
[TBL] [Abstract] [Full Text] [Related]
5. A novel lysosome-targeted fluorescent probe for precise formaldehyde detection in water samples, living cells and breast cancer tumors.
Wang H; Zhang Y; Rong X; Wang B; Wang L; Wang C; Gao W; Ye X; Hou X; Liu W; Wu M; Cheng Y; Shu X; Shang J
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 313():124105. PubMed ID: 38461560
[TBL] [Abstract] [Full Text] [Related]
6. Chitosan nanoplatform for the co-delivery of palbociclib and ultra-small magnesium nanoclusters: dual receptor targeting, therapy and imaging.
Mehata AK; Singh V; Vikas ; Srivastava P; Koch B; Kumar M; Muthu MS
Nanotheranostics; 2024; 8(2):179-201. PubMed ID: 38444739
[TBL] [Abstract] [Full Text] [Related]
7. Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
[TBL] [Abstract] [Full Text] [Related]
8. Effect of physical exercise on immune, inflammatory, cardiometabolic biomarkers, and fatty acids of breast cancer survivors: results from the MAMA_MOVE Gaia After Treatment trial.
Joaquim A; Góis A; Soares A; Garcia C; Amarelo A; Antunes P; Afreixo V; Geraldes V; Capela A; Viamonte S; Alves AJ; Ferreira HB; Guerra I; Afonso AI; Domingues MR; Helguero LA
Support Care Cancer; 2024 Feb; 32(3):174. PubMed ID: 38378875
[TBL] [Abstract] [Full Text] [Related]
9. Differential diagnosis of breast mucinous carcinoma with an oval shape from fibroadenoma based on ultrasonographic features.
Wang H; Hu Y; Tan C; Gu R; Li Y; Jin L; Jiang X; Mei J; Liu Q; Gong C
BMC Womens Health; 2024 Feb; 24(1):87. PubMed ID: 38310239
[TBL] [Abstract] [Full Text] [Related]
10. Folate receptor-mediated delivery system based on chitosan coated polymeric nanoparticles for combination therapy of breast cancer.
Jamali S; Jamali B; Abedi F; Firoozrai M; Davaran S; Vaghefi Moghaddam S
J Biomater Sci Polym Ed; 2024 Apr; 35(5):605-627. PubMed ID: 38271010
[TBL] [Abstract] [Full Text] [Related]
11. Targeted therapies for breast and lung cancers by using Propolis loaded albumin protein nanoparticles.
Ghazy MGM; Hanafy NAN
Int J Biol Macromol; 2024 Mar; 260(Pt 1):129338. PubMed ID: 38232870
[TBL] [Abstract] [Full Text] [Related]
12. Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer.
Li X; Zhang Y; Zhu C; Xu W; Hu X; Martínez DAS; Romero JLA; Yan M; Dai Y; Wang H
BMC Womens Health; 2024 Jan; 24(1):38. PubMed ID: 38218823
[TBL] [Abstract] [Full Text] [Related]
13. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-activated targetable photothermal chemotherapy using IR780/zoledronic acid-containing hybrid polymeric nanoassemblies with folate modification to treat aggressive breast cancer.
Liu YL; Wang TH; Yeh NT; Huang WJ; Tzang BS; Wu IT; Chin HY; Hu SH; Hsu TC; Chiang WH
Nanoscale; 2024 Jan; 16(3):1415-1427. PubMed ID: 38167914
[TBL] [Abstract] [Full Text] [Related]
15. Mucilage-assisted fabrication of molybdenum trioxide nanostructures for photothermal ablation of breast cancer cells.
Alomari RA; Athinarayanan J; Periasamy VS; Alshatwi AA
Biotechnol Appl Biochem; 2024 Apr; 71(2):326-335. PubMed ID: 38112040
[TBL] [Abstract] [Full Text] [Related]
16. Tumour-specific hybrid nanoparticles in therapy of breast cancer.
Kilicay E; Erdal E; Elci P; Hazer B; Denkbas EB
J Microencapsul; 2024 Jan; 41(1):45-65. PubMed ID: 38095892
[TBL] [Abstract] [Full Text] [Related]
17. Are both distinct epithelial and stromal cells molecular analysis from phyllodes tumors versus fibroadenoma components affected in breast fibroepithelial progression?
Waitzberg ÂFL; Ferreira ENE; Pinilla M; Pineda P; Malinverni ACM; Soares FA; Carraro DM
Acta Cir Bras; 2023; 38():e386823. PubMed ID: 38055384
[TBL] [Abstract] [Full Text] [Related]
18. Whole-tumor histogram analysis of multiparametric breast magnetic resonance imaging to differentiate pure mucinous breast carcinomas from fibroadenomas with high-signal intensity on T2WI.
Li X; Chai W; Sun K; Zhu H; Yan F
Magn Reson Imaging; 2024 Feb; 106():8-17. PubMed ID: 38035946
[TBL] [Abstract] [Full Text] [Related]
19. Polyphenol modified CuO nanorods capped by kappa-carrageenan for controlled paclitaxel release in furnishing targeted chemotherapy in breast carcinoma cells.
Singh S; Pal K
Int J Biol Macromol; 2024 Jan; 255():127893. PubMed ID: 37949284
[TBL] [Abstract] [Full Text] [Related]
20. Association between CD10 expression and phyllodes tumor: A retrospective case control study.
Tian F; Zhao J; Shi QF; Zhang DC; Wang YY; Sun JP; Wang Y; Yang SA; Zhang C
Medicine (Baltimore); 2023 Nov; 102(44):e35677. PubMed ID: 37933030
[TBL] [Abstract] [Full Text] [Related]
[Next]
